Biotec staff complete 100 mile bike ride for Ty Hafan
Dedicated staff at Biotec Pharmceutical Services Ltd in Bridgend took part in the 100 mile Cardiff to Tenby bike challenge to raise £400 for Ty Hafan Children’s Hospice.
The 100 mile cycle took most of the team just 9 hours to complete and would have taken them less time if they had not taken a detour round The Gower Peninsula.
Company Director, Marc Weinzweig, Business Development Manager, Matthew Lakelin, Quality Assurance Manager, Tristram Evans and Chairman, Phil Roberts all took part in the challenge that started at 8am. Although all team members are keen cyclists they all found the 100-mile distance in just one day a real challenge, especially having to battle against the wind and cold the whole way.
Matthew Lakelin, said, “I was so delighted to see the sign for Tenby after 9 hours on the bike. We all enjoyed a well-deserved pint or two in the pub afterwards as it helped to reduce the pain we were suffering from our behinds”.
Matthew continued “Prior to the race beginning I was accosted by a guy who was just coming in from a night out and after he asked me what I was doing, he gave me a £1 for the charity and a Cadbury’s Crème Egg for energy. The egg came in very handy later in the day because I missed the lunch stop, so enjoyed it half way up a hill just outside Swansea”.
Although the 100-mile sponsored bike ride was a real challenge for the team, they have decided to make it an annual event in the Biotec calendar and are looking to recruit more staff to take part next year.
Marc Weinzweig, said “Although we raised over £400 for Hy Hafan this year, I would like to see us raise a lot more next year to reach my target of £1000. I am a keen cyclist and I would like to see the event as more of a company event next year so will be scouring the company for willing volunteers for next year”.
Biotec Services International Limited was established in 1997 and works on behalf of global pharmaceutical companies, many located outside the EU, looking to conduct clinical trials and market products in Europe.